CJ Bioscience, Inc. (KOSDAQ: 311690)
South Korea
· Delayed Price · Currency is KRW
11,490
-220 (-1.88%)
Sep 11, 2024, 9:00 AM KST
CJ Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 104,703 | 147,076 | 170,481 | 286,048 | 199,288 | 143,216 | |
Market Cap Growth | -15.44% | -13.73% | -40.40% | 43.53% | 39.15% | - | |
Enterprise Value | 63,854 | 116,989 | 139,502 | 291,080 | 185,214 | 129,115 | |
Last Close Price | 11490.00 | 16140.00 | 24887.51 | 41793.85 | 43939.33 | 32267.94 | |
PE Ratio | - | -4.99 | -4.19 | -9.22 | -19.36 | -24.50 | |
PS Ratio | 20.40 | 26.38 | 41.84 | 65.56 | 37.52 | 29.94 | |
PB Ratio | 1.87 | 2.06 | 3.43 | 3.26 | 5.78 | 4.64 | |
P/FCF Ratio | -4.35 | -4.93 | -6.79 | -30.46 | -9.97 | -48.82 | |
P/OCF Ratio | -4.54 | -5.91 | -8.13 | -33.90 | -24.98 | -57.15 | |
EV/Sales Ratio | 13.03 | 20.98 | 34.24 | 66.72 | 34.87 | 26.99 | |
EV/EBITDA Ratio | -2.57 | -4.35 | -4.76 | -34.06 | -24.82 | -34.09 | |
EV/EBIT Ratio | -2.18 | -3.65 | -4.20 | -28.80 | -21.76 | -28.57 | |
EV/FCF Ratio | -2.44 | -3.92 | -5.56 | -31.00 | -9.26 | -44.02 | |
Debt / Equity Ratio | 0.16 | 0.12 | 0.58 | 0.27 | 1.04 | 0.02 | |
Debt / FCF Ratio | -0.34 | -0.29 | -1.15 | -2.54 | -1.79 | -0.25 | |
Asset Turnover | 0.07 | 0.06 | 0.04 | 0.05 | 0.10 | 0.21 | |
Inventory Turnover | 19.97 | 32.50 | 24.89 | 10.67 | 13.27 | 17.34 | |
Quick Ratio | 3.44 | 4.38 | 1.43 | 3.39 | 13.19 | 13.57 | |
Current Ratio | 3.53 | 4.43 | 1.46 | 3.42 | 13.68 | 13.73 | |
Return on Equity (ROE) | -47.56% | -37.83% | -50.78% | -31.51% | -26.82% | -20.88% | |
Return on Assets (ROA) | -25.83% | -21.95% | -20.00% | -6.66% | -9.94% | -12.13% | |
Return on Capital (ROIC) | -30.21% | -25.26% | -21.82% | -6.94% | -10.45% | -13.33% | |
Earnings Yield | -21.18% | -15.58% | -20.48% | -6.74% | -4.40% | -3.03% | |
FCF Yield | -25.04% | -20.28% | -14.73% | -3.28% | -10.03% | -2.05% | |
Buyback Yield / Dilution | -47.97% | -20.52% | -38.23% | -10.14% | -16.93% | -2.78% | |
Total Shareholder Return | -47.97% | -20.52% | -38.23% | -10.14% | -16.93% | -2.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.